Opportunity Laboratory and Lenexa Medical collaborate for better patient monitoring

Lenexa Medical and the University of Melbourne Opportunity Laboratory (O-Lab) are collaborating to design and test the next generation of LenexaCARE patient monitoring technology – bringing students and industry experts together to create new technology solutions.

LenexaCARE patient monitoring technology solutions enable the prevention and detection of pressure injuries – a global problem that can not only cause death and suffering, but cost the Australian healthcare system over $9 billion in 2021.

The University Faculty of Engineering and Information Technology’s O-Lab brings together teams of industry partners and postgraduate students to collaborate on research projects to build and validate new technology solutions. The Faculty’s Innovation Practice Program, which houses O-Lab, has worked on projects with the Peter MacCallum Cancer Centre, the Royal Melbourne Hospital and IBM.

University of Melbourne Innovation Practice Program Director and Enterprise Senior Fellow in Leadership and Innovation Dr Peter Cebon said: “The Innovation Practice Program aims to exploit the strengths of the University and its corporate partners to generate valuable innovative outcomes. This project strategically injects University expertise and the fresh creativity of students into an exciting new opportunity for Lenexa.”

Lenexa Medical CEO Ajit Ravindran said the grant and project marked an important step in progressing the Lenexa system to optimise patient outcomes.

“Lenexa Medical is passionate about empowering clinicians and carers to deliver a better standard of care,” Mr Ravindran said.

“Joining forces with O-Lab advances our mission to develop innovative and patient-centred technology that supports an overburdened healthcare system and ultimately saves lives.”

The existing LenexaCARE solution has been trialled in several large Victorian hospitals and has been approved for sale in Australia and New Zealand. With Lenexa Medical, the O-Lab project will develop a prototype system for detecting high-risk patient events, as part of the Generation Two offering of the LenexaCARE system.

Lenexa Medical has been awarded an Innovation Connections grant under the AusIndustry Entrepreneurs’ Program to help fund this research. Innovation Connections Facilitator for Victoria, Dr Angela Wu, based at CSIRO, which delivers the program on behalf of the Commonwealth Government said: “The project is a great example of how the Innovation Connections grant supports collaboration between business and universities.”